Insulin Glargine (U-300) Pens and Posaconazole
Determining the interaction of Insulin Glargine (U-300) Pens and Posaconazole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Posaconazole (oral/injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Posaconazole Delayed-Release Tablets
- Insulin Glargine (U-300) Pens-Posaconazole Injection
- Insulin Glargine (U-300) Pens-Posaconazole Intravenous
- Insulin Glargine (U-300) Pens-Posaconazole Oral Suspension
- Insulin Glargine (U-300) Pens-Posaconazole oral/injection
- Insulin Glargine (U-300) Pens-Posaconazole Tablets
- Posaconazole-Insulin glargine and lixisenatide
- Posaconazole-Insulin glargine and lixisenatide Subcutaneous
- Posaconazole-Insulin glargine, recombinant Subcutaneous
- Posaconazole-Insulin glulisine
- Posaconazole-Insulin Glulisine (Cartridges and Pens)
- Posaconazole-Insulin Glulisine (Vials)